BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Tenax Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-19 6:48 pm Purchase | 2024-08-08 | 13G | Tenax Therapeutics, Inc. TENX | BIOTECHNOLOGY VALUE FUND L P | 340,660 9.990% | 340,660 (New Position) | Filing |